首页> 外文期刊>Nephron >Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias.
【24h】

Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias.

机译:长期隧道透析导管相关菌血症的危险因素分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Infection, mainly related to vascular access, is one of the main causes of morbidity and a preventable cause of death in hemodialysis patients. From January 1994 to April 1998 we conducted a prospective study to assess the incidence and risk factors of catheter-related bacteremia. One hundred and twenty-nine tunneled dual-lumen hemodialysis catheters were inserted percutaneously into the internal jugular vein in 89 patients. Bacteremia (n = 56) occurred at least once with 37 (29%) of the catheters (an incidence of 1.1/1,000 catheter-days); local infection (n = 45, 1/1,000 catheter-days) was associated with bacteremia in 18 cases. Death in 1 case was directly related to Staphylococcus aureus (SA) septic shock, and septicemia contributed to deaths in 2 additional cases. Catheters were removed in 48% of the bacteremic episodes. Treatment comprised intravenous double antimicrobial therapy for 15-20 days. Bacteriological data of bacteremia showed 55% involvement of SA. Nasal carriage of SA was observed in 35% of the patients with catheters. Bacteremic catheters were more frequently observed in patients with diabetes mellitus (p = 0.03), peripheral atherosclerosis (p = 0.001), a previous history of bacteremia (p = 0.05), nasal carriage of SA (p = 0.0001), longer catheter survival time (p = 0.001), higher total intravenous iron dose (p = 0.001), more frequent urokinase catheter infusion (p < 0.01), and local infection (p < 0.001) compared with non-bacteremic catheters. Monovariate survival analysis showed that significant initial risk factors for bacteremia were nasal carriage of SA (p = 0.00001), previous bacteremia (p = 0.0001), peripheral atherosclerosis (p = 0.005), and diabetes (p = 0.04). This study confirms the relatively high incidence of bacteremia with tunneled double-lumen silicone catheters and its potential complications. Possible preventive actions are discussed according to the risk factors.
机译:感染主要与血管通路有关,是血液透析患者发病的主要原因之一,也是可预防的死亡原因。从1994年1月到1998年4月,我们进行了一项前瞻性研究,以评估导管相关菌血症的发生率和危险因素。在89例患者中,将129根隧道双腔血液透析导管经皮插入颈内静脉。 37根导管(29%)中至少发生一次细菌血症(n = 56)(发生率为1.1 / 1,000导管日); 18例中,局部感染(n = 45,1 / 1,000导管天)与菌血症相关。 1例死亡与金黄色葡萄球菌(SA)败血症性休克直接相关,败血症导致2例死亡。在48%的细菌发作中删除了导管。治疗包括静脉双重抗菌治疗15-20天。菌血症的细菌学数据显示55%的SA受累。在35%的带导管患者中观察到SA的鼻腔运输。糖尿病患者(p = 0.03),周围动脉粥样硬化(p = 0.001),先前有菌血症史(p = 0.05),SA鼻腔转运(p = 0.0001),导管生存时间更长的患者更常观察到细菌细菌导管(p = 0.001),与非细菌性导管相比,静脉总铁剂量更高(p = 0.001),尿激酶导管输注频率更高(p <0.01)和局部感染(p <0.001)。单变量生存分析表明,菌血症的重要初始风险因素是鼻腔携带SA(p = 0.00001),先前菌血症(p = 0.0001),外周动脉粥样硬化(p = 0.005)和糖尿病(p = 0.04)。这项研究证实了隧穿双腔硅胶导管的菌血症发生率相对较高,并且存在潜在的并发症。根据风险因素讨论了可能的预防措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号